First Interstate Bank’s BioMarin Pharmaceuticals BMRN Stock Holding History

First Interstate Bank’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-2,090	Closed	-$220K	–	777
2015 Q3	$220K	Buy	+2,090	New	+$279K	0.05%	190

Other funds holding BMRN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

First Interstate Bank's BMRN Position: Q4 2015 in Review

First Interstate Bank sold out of BioMarin Pharmaceuticals (BMRN) in Q4 2015, closing a stake of 2,090 shares — an estimated $220K sold.

First Interstate Bank first reported a position in BMRN in Q3 2015 and held it in 1 quarter. The position peaked at $220K in Q3 2015. 388 funds tracked by Wall St. Rank hold BMRN as of Q4 2015.

First Interstate Bank reported no remaining BioMarin Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
First Interstate Bank sold 2,090 BioMarin Pharmaceuticals shares in Q4 2015, an estimated $220K.
First Interstate Bank first reported a position in BioMarin Pharmaceuticals in Q3 2015 and held it in 1 quarter.
First Interstate Bank's BioMarin Pharmaceuticals position peaked at $220K in Q3 2015.
388 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q4 2015.

Based on First Interstate Bank's 13F filing for Q4 2015, filed 2 Feb 2016.